PetMed Express Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 6/6

PetMed Express hat ein Gesamteigenkapital von $96.7M und eine Gesamtverschuldung von $0.0, was einen Verschuldungsgrad von 0% ergibt. Die Gesamtaktiva und Gesamtpassiva betragen $169.9M bzw. $73.2M.

Wichtige Informationen

Verhältnis von Schulden zu Eigenkapital

US$0

Verschuldung

Zinsdeckungsgrad	n/a
Bargeld	US$55.30m
Eigenkapital	US$96.73m
Gesamtverbindlichkeiten	US$73.15m
Gesamtvermögen	US$169.88m

Jüngste Berichte zur Finanzlage

Recent updates

PetMed Express, Inc. (NASDAQ:PETS) Just Reported And Analysts Have Been Cutting Their Estimates

Jun 14

PetMed Express, Inc.'s (NASDAQ:PETS) Intrinsic Value Is Potentially 69% Above Its Share Price

Jun 12

PetMed Express CFO to leave post today, by remain with company over transition period

Aug 02

PetMed Express' (NASDAQ:PETS) Dividend Will Be $0.30

Jul 29

PetMed Express FQ1 2023 Earnings Preview

Jul 24

PetMeds becomes exclusive U.S. fulfillment partner for Vetster, telemedicine platform

Jul 15

Returns On Capital At PetMed Express (NASDAQ:PETS) Paint A Concerning Picture

Jul 04

PetMed Express: 'AutoShip & Save' Program Key Driver Of Growth

May 26

PetMed Express (NASDAQ:PETS) Has Affirmed Its Dividend Of US$0.30

May 13

Silver Ring Value Partners - PetMed Express: Squeezed Out Of Obtaining New Customers

Feb 22

PetMed Express: Avoid For Now

Jan 17

PetMed Express Needs A White Knight

Sep 26

PetMed Express (NASDAQ:PETS) Is Increasing Its Dividend To US$0.30

Jul 29

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: PETSDie kurzfristigen Aktiva des Unternehmens ($93.6M) übersteigen seine kurzfristigen Passiva ($72.2M).

Langfristige Verbindlichkeiten: PETSDie kurzfristigen Vermögenswerte des Unternehmens ($93.6M) übersteigen seine langfristigen Verbindlichkeiten ($995.0K).

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: PETS ist schuldenfrei.

Schulden abbauen: PETS hat in den letzten 5 Jahren keine Schulden gemacht.

Schuldendeckung: PETS hat keine Schulden und muss daher nicht durch den operativer Cashflow gedeckt werden.

Zinsdeckung: PETS hat keine Schulden, daher ist die Deckung der Zinszahlungen kein Problem.

PetMed Express Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 6/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

PetMed Express Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q

PetMed Express, Inc. announced delayed 10-Q filing

PetMed Express, Inc. announced delayed 10-Q filing

Recent updates

PetMed Express, Inc. Announces Appointment of Leah Solivan to Board of Directors

PetMed Express, Inc. (NASDAQ:PETS) Just Reported And Analysts Have Been Cutting Their Estimates

Full year 2024 earnings: EPS misses analyst expectations

New major risk - Revenue and earnings growth

PetMed Express, Inc.'s (NASDAQ:PETS) Intrinsic Value Is Potentially 69% Above Its Share Price

PetMed Express, Inc. Announces Christine Chambers Will Leave the Company in Early August 2024

PetMed Express, Inc. Appoints Carla Dodds as Chief Marketing Officer

PetMed Express, Inc. to Report Q4, 2024 Results on Jun 11, 2024

PetMed Express, Inc. Appoints Justin Mennen to Board of Directors, Effective June 3, 2024

Price target decreased by 21% to US$7.75

PetMed Express, Inc. Announces Executive Changes

PetMed Express Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q

PetMed Express, Inc. announced delayed 10-Q filing

PetMed Express, Inc. announced delayed 10-Q filing

PetMed Express, Inc. to Report Q3, 2024 Results on Feb 08, 2024

PetMed Express, Inc. Announces Management Changes

Independent Chairman of the Board recently bought US$301k worth of stock

CEO, President & Director recently bought US$101k worth of stock

PetMed Express, Inc. Makes Decision to Suspend the Quarterly Dividend Effective the Quarter Ended September 30, 2023

PetMed Express, Inc. to Report Q2, 2024 Results on Oct 30, 2023

Price target decreased by 18% to US$15.00

Now 21% undervalued after recent price drop

A Look At The Fair Value Of PetMed Express, Inc. (NASDAQ:PETS)

PetMed Express (NASDAQ:PETS) Is Paying Out A Dividend Of $0.30

Upcoming dividend of US$0.30 per share at 9.0% yield

First quarter 2024 earnings: EPS and revenues miss analyst expectations

PetMed Express, Inc. to Report Q1, 2024 Results on Jul 31, 2023

Now 21% undervalued after recent price drop

High number of new directors

Consensus EPS estimates fall by 31%, revenue upgraded

Upcoming dividend of US$0.30 per share at 8.1% yield

Full year 2023 earnings: EPS and revenues miss analyst expectations

PetMed Express, Inc. Declares a Quarterly Dividend, Payable on June 12, 2023

PetMed Express, Inc., Annual General Meeting, Aug 03, 2023

Now 22% undervalued after recent price drop

PetMed Express, Inc. Appoints Sandra Y. Campos to its Board of Directors

PetMed Express, Inc. to Report Q4, 2023 Results on May 22, 2023

Consensus EPS estimates fall by 20%

The Returns On Capital At PetMed Express (NASDAQ:PETS) Don't Inspire Confidence

Consensus EPS estimates fall by 48%

PetMed Express (NASDAQ:PETS) Will Pay A Dividend Of $0.30

Third quarter 2023 earnings released: US$0.001 loss per share (vs US$0.21 profit in 3Q 2022)

PetMed Express, Inc. Declares Quarterly Dividend, Payable on February 27, 2023

Investor sentiment improves as stock rises 16%

PetMed Express, Inc. to Report Q3, 2023 Results on Feb 06, 2023

PetMed Express, Inc. entered into an agreement to acquire PetCareRx, Inc. from Evolution VC Partners and Feenix Venture Partners.

PetMed Express, Inc. entered into an agreement to acquire PetCareRx, Inc. from Evolution VC Partners and Feenix Venture Partners.

PetMed Express (NASDAQ:PETS) Will Pay A Dividend Of $0.30

Price target decreased to US$20.67

PetMed Express, Inc. Declares Quarterly Dividend, Payable on November 30, 2022

Price target decreased to US$21.33

PetMed Express, Inc. to Report Q2, 2023 Results on Nov 07, 2022

PetMed Express Puts Are Compelling

Now 21% undervalued after recent price drop

Upcoming dividend of US$0.30 per share

Now 23% undervalued after recent price drop

PetMed Express CFO to leave post today, by remain with company over transition period

Consensus EPS estimates fall by 15%

PetMed Express' (NASDAQ:PETS) Dividend Will Be $0.30

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Petmed Express, Inc. Declares Quarterly Dividend, Payable on August 19, 2022

PetMed Express FQ1 2023 Earnings Preview

PetMed Express, Inc. Announces Executive Changes

PetMeds becomes exclusive U.S. fulfillment partner for Vetster, telemedicine platform

PetMed Express, Inc. to Report Q1, 2023 Results on Jul 25, 2022

Price target decreased to US$23.33

Returns On Capital At PetMed Express (NASDAQ:PETS) Paint A Concerning Picture

PetMed Express, Inc., Annual General Meeting, Jul 28, 2022

PetMed Express, Inc., Annual General Meeting, Jul 28, 2022

PetMed Express: 'AutoShip & Save' Program Key Driver Of Growth

PetMed Express (NASDAQ:PETS) Has Affirmed Its Dividend Of US$0.30

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind